Clonidine transdermal system (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the Clonidine transdermal system drug offered from Actavis Pharma, Inc.. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: Clonidine
SUBSTANCE NAME: CLONIDINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
ROUTE: TRANSDERMAL
DOSAGE FORM: PATCH
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-05-06
END MARKETING DATE: 0000-00-00


Clonidine transdermal system HUMAN PRESCRIPTION DRUG Details:

Item DescriptionClonidine transdermal system from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.1(mg/d)
START MARKETING DATE: 2014-05-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0591-3508_7c40121c-8149-4608-8874-8bd5878a7132
PRODUCT NDC: 0591-3508
APPLICATION NUMBER: ANDA090873

Other CLONIDINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Clonidine transdermal system
Boehringer Ingelheim Pharmaceuticals Inc.Catapres
Corium International, Inc.Clonidine
Lake Erie Medical DBA Quality Care Products LLCClonidine
Mayne Pharma Inc.Clonidine
Mylan Pharmaceuticals Inc.Clonidine
Physicians Total Care, Inc.Clonidine
Rebel Distributors CorpCatapres
Teva Pharmaceuticals USA, Inc.Clonidine